SCHEMBL3136867

SCHEMBL3136867

C=CC(=O)C(C)(C)Cc1ccc(CC(C)(C)C(=O)C=C)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 10/20 0.55
THRA P10827 7/20 0.55
CYP3A4 P08684 4/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
ALDH1A1 P00352 2/20 0.46
BLM P54132 2/20 0.39
ESR1 P03372 3/20 0.39
ESR2 Q92731 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
GRN P28799 1/20 0.35
SORT1 Q99523 1/20 0.35
TGM2 P21980 1/20 0.34
CYP1A2 P05177 2/20 0.33
CYP2D6 P10635 1/20 0.33
NFKB1 P19838 1/20 0.33
KDM4E B2RXH2 1/20 0.33
USP2 O75604 1/20 0.33
EGFR P00533 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16740573 0.91 THRA (0.47) THRBTHRACYP3A4CYP2C9CYP2C19
SCHEMBL8161806 0.91 THRA (0.47) THRBTHRACYP3A4CYP2C9CYP2C19
SCHEMBL16740674 0.91 TGM2 (0.47) THRBTHRACYP3A4CYP2C9CYP2C19
SCHEMBL11092024 0.90 CYP3A4 (0.58) THRBTHRACYP3A4CYP2C9CYP2C19
SCHEMBL9422511 0.89 THRB (0.54) THRBTHRACYP3A4CYP2C9CYP2C19
SCHEMBL16740537 0.88 ALDH1A1 (0.47) THRBTHRACYP3A4ALDH1A1MEN1
SCHEMBL16740667 0.85 TGM2 (0.45) THRBTHRACYP2C19ALDH1A1TGM2
SCHEMBL17544219 0.81 PPARA (0.51) CYP3A4ALDH1A1MEN1KMT2APOLB
SCHEMBL15416126 0.80 CYP2C19 (0.44) THRBTHRACYP3A4CYP2C9CYP2C19
SCHEMBL16740570 0.74 AKR1B1 (0.43) THRBTHRACYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7166274-B2 Synergistically high SPF photoprotective UV-screening compositions comprising insoluble organic sunscreen particles/diarylbutadiene compounds L'OREAL (FR) 2007-01-23 US claimed
US-20040047820-A1 Synergistically high SPF photoprotective UV-screening compositions comprising insoluble organic sunscreen particles/diarylbutadiene compounds SOCIETE L'OREAL S.A. (FR) 2004-03-11 US claimed
US-6627180-B2 Particles having protection factor UV-APPD and an amino substituted 2-hydroxybenzophenone SOCIETE L'OREAL S.A. (FR) 2003-09-30 US claimed
US-20030152532-A1 SYNERGISTICALLY UV-PHOTOPROTECTING COMPOSITIONS COMPRISING MIXED SCREENING AGENTS SOCIETE L'OREAL S.A. (FR) 2003-08-14 US claimed
EP-1317918-A1 Cosmetic sunscreen compositions based on synergistic filter mixture and their use L'OREAL (FR) 2003-06-11 EP claimed
EP-3709966-B1 COMPOSITIONS COMPRISING AT LEAST ONE ACRYLIC POLYMER AND AT LEAST ONE INSOLUBLE ORGANIC SCREENING AGENT OREAL (FR) 2024-12-11 EP disclosed
US-20210346249-A1 COMPOSITION COMPRISING A UV-SCREENING AGENT, AN ANIONIC CROSSLINKED HYDROPHILIC POLYMER, A SURFACTANT HAVING AN HLB LESS THAN OR EQUAL TO 5 AND A SILICONE COPOLYMER L'OREAL (FR) 2021-11-11 US disclosed
CN-107847414-B Composition comprising a UV screening agent, an anionically crosslinked hydrophilic polymer, a surfactant having an HLB less than or equal to 5, and a siloxane copolymer 欧莱雅 2021-09-10 CN disclosed
EP-3185843-B1 GEL COMPOSITION AND GEL COMPRISING A UV FILTER OREAL (FR) 2021-08-11 EP disclosed
EP-2872107-B1 COSMETIC COMPOSITION CONTAINING SCREENING COMPOSITE PARTICLES OREAL (FR) 2021-07-21 EP disclosed
US-20200360264-A1 COMPOSITIONS COMPRISING AT LEAST ONE ACRYLIC POLYMER AND AT LEAST ONE INSOLUBLE ORGANIC SCREENING AGENT L'OREAL (FR) 2020-11-19 US disclosed
CN-111343968-A Composition comprising at least one acrylic polymer and at least one insoluble organic masking agent 莱雅公司 2020-06-26 CN disclosed
US-20040047820-A1 Synergistically high SPF photoprotective UV-screening compositions comprising insoluble organic sunscreen particles/diarylbutadiene compounds SOCIETE L'OREAL S.A. (FR) 2004-03-11 US disclosed
US-6627180-B2 Particles having protection factor UV-APPD and an amino substituted 2-hydroxybenzophenone SOCIETE L'OREAL S.A. (FR) 2003-09-30 US disclosed
US-20030152532-A1 SYNERGISTICALLY UV-PHOTOPROTECTING COMPOSITIONS COMPRISING MIXED SCREENING AGENTS SOCIETE L'OREAL S.A. (FR) 2003-08-14 US disclosed
US-20030129151-A1 Use of amphiphilic copolymers to stabilize dispersions of insoluble organic compounds for screening out UVradiation, dispersions stabilized with these copolymers and cosmetic compositions containing them L'OREAL (FR) 2003-07-10 US disclosed
EP-1317918-A1 Cosmetic sunscreen compositions based on synergistic filter mixture and their use L'OREAL (FR) 2003-06-11 EP disclosed
EP-1302197-A1 Use of amphiphilic copolymers to stabilise dispersions of non-soluble organic compounds filtering UV light L'OREAL (FR) 2003-04-16 EP disclosed
US-20030053966-A1 Insoluble organic UV screening agents of aryl vinylene ketone type, and cosmetic use thereof L'OREAL (FR) 2003-03-20 US disclosed
EP-1281391-A1 Organic insoluble UV filters of the aryl vinylene ketone type and their use in cosmetics L'OREAL (FR) 2003-02-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030129151-A1 Use of amphiphilic copolymers to stabilize dispersions of insoluble organic compounds for screening out UVradiation, dispersions stabilized with these copolymers and cosmetic compositions containing them CUTA, HNRNPU, ERCC5 THRB 4747/4885THRA 4568/4885CYP3A4 2458/4885
US-20200360264-A1 COMPOSITIONS COMPRISING AT LEAST ONE ACRYLIC POLYMER AND AT LEAST ONE INSOLUBLE ORGANIC SCREENING AGENT PCNA, ERCC1, XRCC6 THRB 4670/4885THRA 3101/4885CYP3A4 4560/4885
US-20040047820-A1 Synergistically high SPF photoprotective UV-screening compositions comprising insoluble organic sunscreen particles/diarylbutadiene compounds SUCLG1, CUTA, DLD THRB 4774/4885THRA 4808/4885CYP3A4 1252/4885
US-20030053966-A1 Insoluble organic UV screening agents of aryl vinylene ketone type, and cosmetic use thereof PRKDC, AHR, TYR THRB 4007/4885THRA 2553/4885CYP3A4 535/4885
US-20210346249-A1 COMPOSITION COMPRISING A UV-SCREENING AGENT, AN ANIONIC CROSSLINKED HYDROPHILIC POLYMER, A SURFACTANT HAVING AN HLB LESS THAN OR EQUAL TO 5 AND A SILICONE COPOLYMER ERCC5, CUTA, PLIN5 THRB 1865/4885THRA 2738/4885CYP3A4 3517/4885
US-20030152532-A1 SYNERGISTICALLY UV-PHOTOPROTECTING COMPOSITIONS COMPRISING MIXED SCREENING AGENTS HADHB, SDHA, ERCC4 THRB 3677/4885THRA 4123/4885CYP3A4 700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.